- Home
- OGN vs INDV Comparison
OGN vs INDV Comparison
Compare OGN & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGN
- INDV
- Stock Information
- Founded
- OGN 1923
- INDV 1994
- Country
- OGN United States
- INDV United States
- Employees
- OGN N/A
- INDV N/A
- Industry
- OGN Biotechnology: Pharmaceutical Preparations
- INDV Biotechnology: Pharmaceutical Preparations
- Sector
- OGN Health Care
- INDV Health Care
- Exchange
- OGN Nasdaq
- INDV Nasdaq
- Market Cap
- OGN 2.7B
- INDV 3.1B
- IPO Year
- OGN N/A
- INDV N/A
- Fundamental
- Price
- OGN $6.66
- INDV $24.91
- Analyst Decision
- OGN Buy
- INDV Strong Buy
- Analyst Count
- OGN 3
- INDV 4
- Target Price
- OGN $17.33
- INDV $23.75
- AVG Volume (30 Days)
- OGN 6.0M
- INDV 1.4M
- Earning Date
- OGN 10-30-2025
- INDV 10-30-2025
- Dividend Yield
- OGN 1.20%
- INDV N/A
- EPS Growth
- OGN N/A
- INDV N/A
- EPS
- OGN 2.69
- INDV 0.42
- Revenue
- OGN $6,281,000,000.00
- INDV $1,173,000,000.00
- Revenue This Year
- OGN N/A
- INDV N/A
- Revenue Next Year
- OGN $0.65
- INDV $3.00
- P/E Ratio
- OGN $2.48
- INDV $59.84
- Revenue Growth
- OGN N/A
- INDV 2.27
- 52 Week Low
- OGN $6.39
- INDV $7.62
- 52 Week High
- OGN $19.05
- INDV $25.49
- Technical
- Relative Strength Index (RSI)
- OGN 16.88
- INDV 58.74
- Support Level
- OGN $8.87
- INDV $23.72
- Resistance Level
- OGN $9.28
- INDV $25.47
- Average True Range (ATR)
- OGN 0.35
- INDV 0.77
- MACD
- OGN -0.30
- INDV 0.04
- Stochastic Oscillator
- OGN 6.84
- INDV 75.32
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.